Site Search

Share

X

Search Results

Cancer Survivors Convene in Hartford, Urge Lawmakers to Expand Access to Biomarker Testing

HARTFORD – May 9, 2025 – Yesterday, the Connecticut House voted in unanimous support of legislation that would ensure biomarker testing is covered by state regulated insurance plans, including Medicaid, when supported by scientific and medical evidence. The goal of the ... a statement from Bryte Johnson, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in Connecticut: “Biomarker testing is essential to high-quality, personalized care for many conditions and can be a real gamechanger for many patients, but ...

Cancer Survivors Convene in Hartford, Urge Lawmakers to Expand Access to Biomarker Testing

... diseases like cancer. With this in mind, the volunteers asked lawmakers to improve private insurance coverage of comprehensive cutting edge biomarker testing across all communities. Last year, the legislature acted to ensure such access for Medicaid enrollees, but private insurance companies were not included. Because insurance coverage of biomarker testing has not kept pace with the speed of medical innovation, communities in Connecticut are facing significant disparities in who is ...

NJ Assembly Financial Institutions & Insurance Committee Votes to Improve Access to Biomarker Testing

Today, the Assembly Financial Institutions & Insurance Committee voted to improve New Jerseyans’ access to biomarker testing, advancing Assembly Bill 4163 out of committee. Championed by Assemblymembers Shavonda Sumter, Gary Schaer and Shama Haider, the proposal would ensure biomarker testing is covered by New Jersey-regulated insurance plans, including Medicaid, when medical and scientific evidence shows it would ...

Florida needs to increase access to game-changing cancer tests

... Cancer Society Cancer Action Network (ACS CAN), we at Florida Cancer Specialists & Research Institute (FCS) are working to improve access to biomarker testing, including innovative diagnostic tests that can provide game-changing information for cancer treatment. Thanks to modern medical breakthroughs, when someone is diagnosed with cancer and when clinically appropriate, we use biomarker testing to precisely identify the mutations unique to a patient’s cancer. Biomarker testing has revolutionized the entire approach to ...

ACS CAN Statement on Nevada Biomarker Legislation

... – The Nevada State Legislature passed Assembly Bill 155 as the 82nd legislative session adjourned, Monday. The bill establishes provisions for biomarker testing in Nevada but falls short of ensuring broader patient access to needed testing. While the American Cancer Society Cancer Action Network (ACS CAN) appreciates lawmakers’ recognition of the growing importance of biomarker testing in the treatment of cancer and other conditions, this bill was significantly weakened from its original intent.  The bill was ...

Legislation Introduced to Increase Pennsylvanians’ Access to Biomarker Testing, the Key to Precision Medicine

HARRISBURG, PA – OCTOBER 12, 2023 – Today, Rep. Kyle Mullins introduced House Bill 1754 to increase Pennsylvanians’ access to biomarker testing, following Sen. Devlin Robinson’s introduction of a companion bill, Senate Bill 954, in the Senate last week. A game-changing part of cancer care, biomarker testing opens the door to targeted therapy and personalized medicine which can improve patient survivorship and quality of life. This is ...

Health Care Providers Call on Governor Hochul to Sign Biomarker Testing Bill without Delay

... gathered today at the Northwell Health Cancer Institute to call on Governor Kathy Hochul to prioritize health equity by improving access to biomarker testing and signing Senate Bill 1196a / Assembly Bill 1673a into law. Senate Bill 1196a / Assembly Bill 1673a seeks to ensure comprehensive biomarker testing is covered by all state-regulated health plans, including Medicaid, when medically appropriate. The bill passed the Legislature ...

Legislation Introduced to Increase Californians’ Access to Biomarker Testing, the Key to Precision Medicine

Sacramento, Calif. — Today, State Senator Monique Limón (D-Santa Barbara) introduced legislation to ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 496 aims to enable more Californians to benefit from biomarker testing, a critical step for accessing precision medicine, including targeted therapies, that can lead to improved survivorship and ...

Iowa House of Representatives Declares March as Precision Medicine and Biomarker Testing Awareness Month

... of these efforts, the House of Representatives of the State of Iowa issued a resolution designating March of each year as Precision Medicine and Biomarker Testing Awareness Month. Dubbed ‘the right treatment, to the right patient, at the right time,’ precision medicine has played a critical role in improving cancer outcomes. For example, patients with certain types of lung cancer who received biomarker testing had a 28% reduction in mortality. But in order to determine if a patient will benefit from certain targeted therapies, doctors ...

Governor Signs Legislation Taking First Step to Improving Access to Biomarker Testing for Floridians

TALLAHASSEE, Fla. ‑‑  Gov. Ron DeSantis signed HB885 into law today, which expands patient access to biomarker testing, a key tool used by physicians to identify the most effective treatment of cancer and other diseases. In the case of a cancer diagnosis, biomarker testing allows doctors to develop a personalized treatment plan. It opens the door to the use of targeted therapy, which can result in ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy